SequelSEC

QHSLab, Inc. USAQ

Surgical & Medical Instruments & Apparatus · CIK 0000856984 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$3.02M
Fiscal year ended 2026-06-30
Operating income
$82.62K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$1.56MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.10Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
SBC / revenue0.0%0th
Long-term debt / equity0.06x4th
Revenue YoY growth26.3%73th
Operating margin4.9%71th
Current ratio1.96x36th
Gross margin67.3%64th
R&D / revenue18.0%55th

QHSLab, Inc. (USAQ) reported revenue of $3.02M and net income of -$390.73K for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from QHSLab, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

QHSLab, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$3.02M
Cost of revenue$974.57K
Gross profit$2.04M
Operating income$82.62K
Net income-$390.73K
Research & development$484.01K
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$1.40M
General & administrative$648.21K
Selling & marketing$755.53K

Balance

QHSLab, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$317.39K
Total assets$1.93M
Current assets$682.93K
Total liabilities$375.82K
Current liabilities$375.82K
Total equity incl. NCI$1.56M
Temporary (mezzanine) equityUnavailable
Inventory$8.81K
Accounts receivable$342.89K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$248.48K

Cash flow

QHSLab, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$463.66K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$256.46K
Net change in cash$149.03K
Stock-based compensation$0
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$72.11K

Derived

QHSLab, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin67.7%
Operating margin2.7%
FCF marginUnavailable
SBC / revenue0.0%
Current ratio1.82x
Revenue YoY growth24.6%
Net margin-13.0%
R&D / revenue16.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USAQ in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.